Atlas Trials

Study to Evaluate the Treatment Effect of PT003 on Cardiovascular Hemodynamics in Subjects With Moderate to Severe COPD

Clinical trial NCT02685293 · TERMINATED

Trial details

NCT number
NCT02685293
Sponsor
Pearl Therapeutics, Inc.
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
COPD
Start date
2016-12-09
Primary completion
2018-06-06
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.